Gezell, through its partnership with the Université de Sherbrooke, develops semiconductor integrated circuits for incorporation into implantable neuromodulation devices.

These devices are typically custom designed for a specific device, balancing various attributes including power consumption, chip size, electrode size and density, and of course electrical parameters for stimulation and recording.